EL 📈 EssilorLuxottica S. A. - Overview

Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0000121667

EL: Lenses, Frames, Sunglasses, Equipment, Instruments, Eyewear

EssilorLuxottica Société anonyme is a global leader in the design, manufacture, and distribution of ophthalmic lenses, frames, and sunglasses. The company operates in multiple regions, including Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America, through its two main segments: Professional Solutions and Direct to Consumer.

EssilorLuxottica offers a wide range of lenses under renowned brands such as Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, and others. Additionally, the company provides high-quality frames and sunglasses under iconic brands like Ray-Ban, Oakley, Persol, Oliver Peoples, and Vogue Eyewear, among others.

The company's Professional Solutions segment offers a variety of products and services to eyecare professionals, including finishing equipment, vision performance screening, eye examination and refractions, fitting parameter measurements, and small tools and consumables under the Essilor Instruments brand. It also provides high-tech equipment for optical surfacing, polishing, measuring, coating, and finishing, as well as consumables, tools, and services under the Satisloh brand.

In addition to its product offerings, EssilorLuxottica designs, develops, markets, and maintains lens edging and mounting instruments for opticians and prescription laboratories, as well as optometry instruments for eyecare professionals, schools, occupational medicine centers, military, and other institutions.

The company distributes its products to a wide range of customers, including independent opticians, distributors, third-party e-commerce platforms, and large retail chains in the eyecare and eyewear industry. It also sells directly to consumers through its network of brick and mortar retail stores and online channels.

EssilorLuxottica has a rich history, dating back to 1849, and is headquartered in Paris, France. The company has undergone significant transformations, including a name change from Essilor International Société Anonyme to EssilorLuxottica Société anonyme in October 2018, following the merger with Luxottica.

Additional Sources for EL Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

EL Stock Overview

Market Cap in USD 114,500m
Sector Healthcare
Industry Medical Instruments & Supplies
GiC Industry Health Care Equipment & Supplies
TER 0.00%
IPO / Inception

EL Stock Ratings

Growth 5y 70.3%
Fundamental 71.9%
Dividend 59.3%
Rel. Performance Sector 1.53
Analysts -
Fair Price Momentum 242.91 EUR
Fair Price DCF 315.36 EUR

EL Dividends

Dividend Yield 12m 1.73%
Yield on Cost 5y 3.06%
Annual Growth 5y 9.63%
Payout Consistency 97.94%

EL Growth Ratios

Growth Correlation 3m 93.2%
Growth Correlation 12m 89.2%
Growth Correlation 5y 90.5%
CAGR 5y 11.81%
CAGR/Mean DD 5y 1.20
Sharpe Ratio 12m 1.17
Alpha 4.04
Beta 0.63
Volatility 17.59%
Current Volume 535.2k
Average Volume 20d 561.3k
What is the price of EL stocks?
As of December 04, 2024, the stock is trading at EUR 228.50 with a total of 535,176 shares traded.
Over the past week, the price has changed by -1.50%, over one month by +5.59%, over three months by +7.92% and over the past year by +32.71%.
Is EssilorLuxottica S. A. a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, EssilorLuxottica S. A. (PA:EL) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 71.86 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EL as of December 2024 is 242.91. This means that EL is currently overvalued and has a potential downside of 6.31%.
Is EL a buy, sell or hold?
EssilorLuxottica S. A. has no consensus analysts rating.
What are the forecast for EL stock price target?
According to ValueRays Forecast Model, EL EssilorLuxottica S. A. will be worth about 265.7 in December 2025. The stock is currently trading at 228.50. This means that the stock has a potential upside of +16.26%.
Issuer Forecast Upside
Wallstreet Target Price 219.1 -4.1%
Analysts Target Price - -
ValueRay Target Price 265.7 16.3%